|1.||Chan, Shun-An: 1 article (01/2007)|
|2.||Lin, Shan-Yang: 1 article (01/2007)|
|3.||Hsieh, Tzu-Feng: 1 article (01/2007)|
|4.||Wang, Shun-Li: 1 article (01/2007)|
|5.||Miura, N: 1 article (05/2000)|
|6.||Tanaka, Y: 1 article (05/2000)|
|7.||Yamanouchi, K: 1 article (05/2000)|
|8.||Oosuka, I: 1 article (05/2000)|
02/01/1997 - "AVP at 10(-8) M and Z-321 at 10(-4) M augmented the potentiation induced by the weak tetanus; the magnitude of the post-tetanic potentiation of the EPSP was enhanced and the potentiation lasted for 60 min. In contrast, the racemic D-thioprolyl compound of Z-321, which virtually lacks any inhibitory effects on PEP, failed to affect the potentiation at 10(-4) M. "
02/01/1997 - "The present study investigated the effects of arginine-vasopressin (AVP) and (1-[3-(2-indanylacetyl)-L-thioprolyl] pyrrolidine (Z-321), an inhibitor of prolyl endopeptidase (PEP; (EC 18.104.22.168)) which degrades AVP in vitro, on the short-lasting potentiation of the field excitatory postsynaptic potentials (EPSP) coupled with a weak tetanus. "
|2.||Weight Loss (Weight Reduction)
|1.||Arginine Vasopressin (Argipressin)
|3.||prolyl oligopeptidase (prolyl endopeptidase)
|6.||Dihydrotachysterol (AT 10)